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ABSTRACT 
Colorectal Cancer (CRC) is the fourth leading cause of cancer death in the world. Epidemiological studies have 
shown an association between CRC incidence/mortality with unhealthy dietary habits, which suggests the need to 
promote and protect health through the adoption of sustainable measures that allow the reduction of morbidity and 
mortality rates, such as the consumption of products of plant origin. Some phytochemicals derived from fruits have 
shown antiproliferative activity and high antioxidant capacity; however, few research advances have been obtained 
regarding the complex mixture of phytochemicals of certain fruits that could contain promising bioactive 
substances. For these reasons, in the present work we evaluated the cytotoxic activity and the pro-apoptotic 
potential of the aqueous extract of P. edulis Sims var. Flavicarpa on an in vitro CRC model. Chemical analysis of 
the extract was based on a preliminary phytochemical screening in which were identified metabolites such as 
phenolic compounds and sterols, which have displayed antitumoral properties. The extracts exerted cytotoxic and 
proapoptotic potential, demonstrated by the reduction on cell viability, increase of the SubG0/G1 cell populations 
and the positive staining with Annexin-V of treated cells. Our results suggest that P. edulis is a potential source of 
phytochemical compounds with cytotoxic and apoptotic potential over colon cancer cell lines. 
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INTRODUCTION 
Colorectal cancer (CRC) is the third most diagnosed cancer in men and the second in women in the world, with 
nearly 693.900 deaths and 1.4 million new cases diagnosed in 2012, [1] it is important to note that more than 50% of 
the cases were diagnosed in developed countries [2]. The appearance and progression of the disease are related to 
environmental and genetic factors; one of these is dietary habits, which has been associated with more than 50% of 
mortality cases. This can be explained due to presence of carcinogenic substances in the food, high fat consumption, 
carbohydrates and alcohol, and also for the low consumption of food with chemoprotective agents such as fruits and 
vegetables [3,4]. Several studies have identified a relationship between the consumption of fruits, vegetables, 
legumes and tea, and a decrease in the incidence of some cancer types; effects that have been associated with high 
content of bioactive compounds (phytochemicals) in the diet [5]. Chemoprotective features are associated to the 
consumption of dietary fiber, some micronutrients (A, E, C, and D vitamins, folate and carotenoids, minerals, 
selenium and calcium) and polyphenols [6], with antioxidant, antigenotoxic, anti-inflammatory and antiproliferative 
potential, which can prevent the initiation of colorectal cancer and reverse or delay the progression process [3,7].  
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The species Passiflora edulis, known as Maracuya, parchita, or passion fruit, is cultivated in tropical and subtropical 
countries. The P. edulis Sims var. flavicarpa variety has yellow fruits and grows from sea level to 1.000 m [8]. 
Different parts of the plant have been used in traditional medicine to treat neurological disorders (insomnia, 
epilepsy, hypnosis and sedation), heart disease (hypertension, diuretics, cholesterol and reduction of triglyceride 
levels), muscle relaxants (antispasmodics, stomachache relievers), which can be explained by the bioactive 
properties reported for this fruit [9,10]. Also, it have been demonstrated the capacity of P. edulis to inhibit the 
activity of MMP-2 and MMP-9 proteins, two metalloproteinases involved in tumor invasion, metastasis and 
angiogenesis [11]. Similarly, ethanol and aqueous extracts displayed antioxidant activity and its effect to reduce cell 
viability of colon cancer cell lines has been shown [12]. For these reasons, this plant is promising to be investigated 
in search of bioactive compounds to control and prevent carcinogenic processes. In the present study, it was 
evaluated the potential of an aqueous extract obtained from the fruit of P. edulis Sims var. flavicarpa plant, to 
regulate cell cycle and also to test its cytotoxic and pro-apoptotic potential on an in vitro CRC model. 
METHODOLOGY 
Extraction and Characterization  
The aqueous extracts were obtained from P. edulis Sims var. Flavicarpa fruits, collected in La Tebaida, Colombia; 
the specimens were identified by the Herbarium of Universidad del Quindio (collection number: 33974). The edible 
part was macerated and filtered, then left for 96 hours at 60°C and finally dried and stored at 4°C (protected from 
light). For the chemical characterization, a preliminary phytochemical screening was performed according to Bilbao, 
M [13].  
 
Cell Culture 
SW480 cell line established from human colon adenocarcinoma and SW620 cell line established from lymph node 
metastases of the same patient [14], were obtained from the American Type Culture Collection (ATCC, Manassas, 
USA). Cells were cultivated according to the procedure used by Maldonado et al. [15], the propagation was done 
with DMEM (Gibco) medium with 25 mM glucose and 2 mM L-glutamine, supplemented with 10% horse serum 
(HS), 100 UI/ml penicillin, 100 μg/ml streptomycin and 1% of non-essential amino acids. The cell cultures were 
maintained at 37°C and 5% CO2. During the experiments, serum was reduced to 3%, and the medium was 
supplemented with insulin (10 μg/ml), transferrin (5 μg/ml) and Selenium (5 ng/ml). The treatments were added in 
volume/volume ratios in all cases.  
 
Cytotoxicity Assessment  
Cell cultures with viability higher than 95% were seeded in a density of 5,000 cells/well for 48 hours. Afterwards, 
cells were treated at the following concentrations of the extract: 10% (264 µg/ml), 7% (184.8 µg/ml), 5% (132 
µg/ml), 2% (52.8 µg/ml), and 1% (26.4 µg/ml); the negative control were untreated cells in culture medium (C-), the 
positive control were cells with turmeric extract at 100 µg/ml (C+). After 24 hours, 20µl of MTT (3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) were added, (5mg/ml per well), and incubated at 37°C and 
5% CO2 for 4 hours. Then, 100 µl of acid isopropanol (Triton X-100 10%, HCl 0.8%) were added per well, and kept 
in darkness for 30 minutes at room temperature. Measurements of absorbance were performed using GlomaxTM 
multidetection system (Promega) at 560 nm, and the percentage of viability was estimated as: Viability % = 
(ODt/ODc) × 100, where ODt=optic density of treated cells, and ODc=optic density of control cells (untreated 
cultures). Seven replicates per treatment were performed.  
 
Effects on Cell Cycle 
Cultures were treated with 444 µg/mL and 415 µg/mL of the extract as previously described [12]. After treatments, 
cells were collected and fixed with 1ml Methanol-PBS 9:1 (v/v) proportion, and stored at -20°C for 2 hours. 
Thereafter, cells were centrifuged at 2500 rpm for 5 minutes and the excess of methanol was removed. Finally, cells 
were resuspended in 300 µl PBS with 250 µg/ml RNase A and 10 µg/ml propidium Iodide and incubated at room 
temperature for 30 minutes in darkness. The samples were analyzed in FACS Canto II flow cytometer.  
 
Apoptosis Induction Effect 
3 ×10
5 
SW480 and SW620 cells were seeded in 2 ml of culture medium and incubated for 48 hours. Then, cells were 
treated as described in the previous section. At the end of the experiment, supernatant was collected and cells were 
detached and centrifuged at 2500 rpm for 5 minutes. Thereafter, 1x10
6 
cells were collected in 1ml of Annexin V Kit 
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binding buffer (10 mM Hepes; 0.14 M NaCl; 2.5 mM CaCl2; pH 7.4) and 4 µl of Annexin V-FITC (Annexin-V–
FLUOS staining kit) and 10 µL of propidium iodide (1mg/mL) were added. The samples were incubated for 15 
minutes at 4°C in darkness and 1 ml of PBS was added prior to centrifugation in order to remove the supernatant. 
The samples were analyzed in FACS Canto II flow cytometer.  
 
Statistical Analysis  
The data was analyzed with the program GraphPad Prism 6.0 (GraphPad Software Inc., San Diego, CA) using One 
Way Analysis of Variance (ANOVA) and Duncan test to compare each treatment with the negative control. In every 
case, statistically significant differences were considered at p ≤ 0.05. 
 
 RESULTS AND DISCUSSION 
Preliminary Phytochemical Screening  
Table 1 shows the secondary metabolites identified in P. edulis Sims var. Flavicarpa fruits, like flavonoids and 
quinones, which have been shown to possess biological activity associated with the prevention of different types of 
cancer [15,16]. The chemopreventive properties of these polyphenols are related to its anti-proliferative, antioxidant 
and anti-inflammatory activity, effects on cell cycle and apoptosis, enzyme detoxification induction, immune system 
regulation and the modulation of different cell signaling pathways [17]; particularly, in CRC it has been widely 
validated its anti-mutagenic and anti-carcinogenic activity [15,18-23]. Flavonoids are particularly relevant, since the 
phenolic rings they possess have the ability to accept an electron to form relatively stable phenoxyl radicals that 
protect the cell from damage produced by oxidative reactions. Likewise, they have shown to exert cytotoxic effects 
against cancer cells, through cell cycle arrest and apoptosis induction [24,25]. 
Table 1: Qualitative evaluation of metabolites present in extracts of P. edulis Sims f. Flavicarpa 
Metabolite Presence(+)/ Absence(-) 
Tannis - 
Flavonoids + 
Quinones + 
Sterols + 
Saponines - 
Cardiac glycosides + 
Terpene lactones - 
Coumarins - 
Alkaloides + 
Deoxisugars + 
Reducing sugars + 
 
Regarding sterols present in the extract, increasing evidence points out their relationship with a lower risk of 
developing cancer and their application in the therapeutic field [26,27]. For Pasiflora genus, different studies have 
reported the presence of bioactive compounds [9,28,29], as well as antioxidant activity of leaf [12] and seeds 
extracts [30]. Overall, extracts from different parts of P. edulis plant contain different flavonoids, quinones and 
sterols, which display high antioxidant activity [28].  
 
Effect of Aqueous P. edulis Extract on Cell Viability in SW620 and SW480 Cell Lines 
In order to estimate the decrease on cell viability within 24 hours of treatment, we performed an MTT Assay. In this 
manner, it was observed that SW480 cells displayed significant differences between treated and non-treated cells 
(p<0.0001), being the treatment at 10% of extract (264 µg/ml), the one that showed the highest reduction on cell 
viability (16.98%) (Figure 1) however, the regression analysis did not show a lineal correlation between extract 
concentration and viability percentage (R2=0.2352). Likewise, for SW620 cells significant differences were 
observed between treated and non-tretaed cells (p < 0.0001), being the highest reduction on cell viability (18.50%) 
at the same concentration that was found for SW480 cells. Nevertheless, the regression analysis did not show an 
effect of extract concentration on SW620 viability percentage (R2=0.2352). SW480 and SW620 cell lines have been 
widely studied given their isogenic features for which they have been validated as an in vitro model for colon cancer 
[31]. Cytotoxic activity of the extract displayed a dose-dependent response in both cell lines, but the concentration 
required to reach the half maximal inhibitory concentration (IC50) must be higher than 264 µg/ml. Our results are 
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similar to IC50 dose reported by Aguillon et al. who tested P. edulis juice and found an IC50 of 444 µg/ml and 415 
µg/ml for SW480 and SW620, respectively [12]. It is important to note that these concentrations are considerably 
higher than 30 µg/ml, which is the reference concentration established by the National Cancer Institute (NCI) in 
United States, to consider an extract with promising bioactivity [32]; because of this, the extracts tested on this assay 
could be considered low activity extracts. However, other authors, such as Neira, have found different fractions of P. 
edulis juice (an ethanolic fraction and a hydro soluble fraction with carotenoids and polyphenols) which inhibits 
growth of MOLT-4 human T cells at concentrations under 30 µg/ml [33]. Silva et al. tested an aqueous fraction rich 
in polysaccharides in the human colon adenocarcinoma cell line HCT-8, in which they found an IC50 of 0.36 µg/ml 
and in the human leukemia cell line HL- 60 they found an IC50 of 12.59 µg/ml [34]. As a whole, this data suggest 
that the cytotoxic effect of P. edulis extracts depends on the part of the plant used, the extraction method and the cell 
line tested. 
 
Figure 1: Cytotoxic effect of the aqueous extract of the P. edulis fruit on SW480 and SW620 cell lines after 24 hours of treatment 
 
Effect of Aqueous Extract Obtained from P. edulis Fruit over Cell Cycle on SW620 and SW480 Cell Lines 
Figure 2 presents the cell cycle distribution after treatments for 48 hours at 444 µg/mL and 415 µg/mL of the 
aqueous extract, for SW480 and SW620 cell lines, respectively. A significant increase in the percentage of 
hypodiploid cells (SubG0/G1 cell population) and a significant reduction of G2/M population was observed in cells 
treated with P. edulis aqueous extract and with turmeric extract. These results suggest that both extract possess 
phytochemicals with growth inhibitory properties that may be related to cell death mechanisms. Even though this 
approach allows to determine the amount of dead or dying cells in a population but gives no information on the cell 
death process (apoptosis or necrosis), we hypothesize that the mechanism induced is apoptosis as described for 
polyphenols like epigallocatechin gallate (EGCG) from green tea [35]. Theaflavin and Tearubigin from black tea 
[36] and polyphenols from olive leaf extract (hydroxytyrosol and oleuropein) [37-39].  
 
Figure 2: Cell cycle distribution in SW480 cells (right) and SW620 cells (left), treated with Passiflora edulis F. flavicarpa aqueous extract 
Apoptosis Induction of P. edulis Aqueous Extract over SW620 and SW480 Cell Lines 
Table 2 shows the results of the apoptosis induction by P. edulis fruit over SW480 and SW620 cell lines. For both 
cell lines, significant apoptosis levels were observed, being higher than 45% in SW480 cells and higher than 49% in 
SW620 cells. These results confirm that the SubG0/G1 cell population observed in the cell cycle distribution 
experiments (Figure 3) correspond to apoptotic cells.  
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Table 2: Apoptosis induction by P. edulis aqueous extract on SW480 and SW620 cell lines 
Cell line Population % Viable cells % Necrotic cells 
% Cells in early 
apoptosis 
% of cells in late 
apoptosis 
SW480 
C- 96.8 ± 0.7 0.3 ± 1.4 1.4 ± 1.3 1.5 ± 0.7 
C+ 36.8 ± 2.9 5.1 ± 0.3 24.8 ± 0.6* 33.3 ± 1.7* 
P. edulis aqueous extract (444µg/mL) 51.0 ± 0.1 3.7 ± 0.7 10.4 ± 2.6* 34.9 ± 0.2* 
SW620 
C- 96.4 ± 0.8 0.7 ± 0.5 1.2 ± 2.1 1.7 ± 0.5 
C+ 27.5 ± 1.1 10.1 ± 1.5 17.2 ± 2.2* 45.2 ± 1.4* 
P. edulis aqueous extract (415 µg/mL) 46.6 ± 0.1 3.5 ± 2.1 11.8 ± 1.8* 38.1 ± 0.3* 
(*significant difference) 
 
Figure 3: Scatter plot of the apoptosis inducing effect of the aqueous extract of passion fruit on SW480 cells 
 
Figure 4: Scatter plot of the apoptosis inducing effect of the aqueous extract of passion fruit on SW620 cells exposed for 48 hours 
This increase in the apoptotic levels can be related to the presence of flavonoids, quinones, sterols, and cardiac 
glycosides in the extract (Figure 4), as previously demonstrated on in vitro cancer models [40]. In the case of 
flavonoids, it has been demonstrated its capacity to modulate several signaling pathways involved in cell 
proliferation, migration and survival, like NFKβ, MAPK, Wnt/β-catenin and also the regulation of cell death 
mechanisms, like the induction of caspases proteins [41,42]. 
CONCLUSION 
This study demonstrates that aqueous extract of Passion fruit (P. edulis) has proapoptotic and cytotoxic potential on 
an in vitro colon cancer model. For these reasons, along with the presence of several phytochemicals like 
polyphenols, sterols and cardiac glycosides in the extract, P. edulis can be considered as a promissory species for the 
search for phytotherapeutic or phytopreventive compounds for the management of colon cancer.  
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